3-((5Z)-5-[3-(Allyloxy)benzylidene]-4-oxo-2-thioxothiazolidin-3-yl]-1-(4-chlorophenyl)pyrrolidine-2,5-dione

ID: ALA5190433

PubChem CID: 168058219

Max Phase: Preclinical

Molecular Formula: C23H17ClN2O4S2

Molecular Weight: 484.99

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CCOc1cccc(/C=C2\SC(=S)N(C3CC(=O)N(c4ccc(Cl)cc4)C3=O)C2=O)c1

Standard InChI:  InChI=1S/C23H17ClN2O4S2/c1-2-10-30-17-5-3-4-14(11-17)12-19-22(29)26(23(31)32-19)18-13-20(27)25(21(18)28)16-8-6-15(24)7-9-16/h2-9,11-12,18H,1,10,13H2/b19-12-

Standard InChI Key:  OGPJVFDQWRHEHV-UNOMPAQXSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.3420    1.9839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2599    1.1630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5336    0.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9440    1.7103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3967    2.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5608    3.1332    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8619    0.2600    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4515   -0.4513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0261   -1.0807    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7649   -0.7524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6828    0.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2848    0.6158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4764   -1.1628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4764   -1.9837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7649   -2.3942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7649   -3.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4764   -3.6255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1878   -3.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1878   -2.3942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3420   -0.5608    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.8619    0.6158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0533    2.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0533    3.2153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7649    3.6257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4764    3.2153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4764    2.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7649    1.9839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1878    3.6257    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0536   -3.6257    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3423   -3.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3689   -3.6257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0803   -3.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  5  6  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
  9 10  1  0
  7 11  1  0
 11 10  1  0
 11 12  2  0
 10 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 19  2  0
  8 20  2  0
  2 21  2  0
  1 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 27  2  0
 25 28  1  0
 16 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5190433

    ---

Associated Targets(Human)

LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 484.99Molecular Weight (Monoisotopic): 484.0318AlogP: 4.44#Rotatable Bonds: 6
Polar Surface Area: 66.92Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 7.41CX Basic pKa: CX LogP: 4.83CX LogD: 4.54
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.26Np Likeness Score: -1.46

References

1. Finiuk N, Kryshchyshyn-Dylevych A, Holota S, Klyuchivska O, Kozytskiy A, Karpenko O, Manko N, Ivasechko I, Stoika R, Lesyk R..  (2022)  Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation.,  238  [PMID:35533562] [10.1016/j.ejmech.2022.114422]

Source